OpenURL Connection Search

Select item for more details and to access through your institution.

Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases.
Published in:
Neuroendocrinology, 2017, v. 106, n. 1, p. 74, doi. 10.1159/000479293
By:
- Ronot, Maxime;
- Clift, Ashley K.;
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Frilling, Andrea;
- Vilgrain, Valérie
Publication type:
Article
Theranostics of Neuroendocrine Tumors.
Published in:
Visceral Medicine, 2017, v. 33, n. 5, p. 358, doi. 10.1159/000480383
By:
- Sze Ting Lee;
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Baum, Richard P.
Publication type:
Article
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.
Published in:
2020
By:
- Sahakyan, Karine;
- Li, Xin;
- Lodge, Martin A.;
- Werner, Rudolf A.;
- Bundschuh, Ralph A.;
- Bundschuh, Lena;
- Kulkarni, Harshad R.;
- Schuchardt, Christiane;
- Baum, Richard P.;
- Pienta, Kenneth J.;
- Pomper, Martin G.;
- Ross, Ashley E.;
- Gorin, Michael A.;
- Rowe, Steven P.
Publication type:
journal article
Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer.
Published in:
EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0538-1
By:
- Müller, Cristina;
- Singh, Aviral;
- Umbricht, Christoph A.;
- Kulkarni, Harshad R.;
- Johnston, Karl;
- Benešová, Martina;
- Senftleben, Stefan;
- Müller, Dirk;
- Vermeulen, Christiaan;
- Schibli, Roger;
- Köster, Ulli;
- van der Meulen, Nicholas P.;
- Baum, Richard P.
Publication type:
Article
First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma.
Published in:
Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1, doi. 10.2967/jnumed.124.268074
By:
- Kulkarni, Harshad R.;
- Maupin, Kevin A.;
- Brennan, Tina;
- Forsberg, Jens;
- Rogers, Dan;
- Olson, Mark;
- Mancini, Brandon R.;
- Chang, Anthony;
- Chandana, Sreenivasa R.;
- Kobayashi, Ryohei
Publication type:
Article
Prostate-specific membrane antigen radioligand therapy using 177Lu-PSMA I&T and 177LuPSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262713
By:
- Schuchardt, Christiane;
- Jingjing Zhang;
- Kulkarni, Harshad R.;
- Xiaoyuan Chen;
- Müller, Dirk;
- Baum, Richard P.
Publication type:
Article
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: Firstin- Human Results.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259192
By:
- Baum, Richard P.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Chantadisai, Maythinee;
- Robiller, Franz C.;
- Jingjing Zhang;
- Mueller, Dirk;
- Eismant, Alexander;
- Almaguel, Frankis;
- Zboralski, Dirk;
- Osterkamp, Frank;
- Hoehne, Aileen;
- Reineke, Ulrich;
- Smerling, Christiane;
- Kulkarni, Harshad R.
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: Firstin-Human Results.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259192
By:
- Baum, Richard P.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Chantadisai, Maythinee;
- Robiller, Franz C.;
- Jingjing Zhang;
- Mueller, Dirk;
- Eismant, Alexander;
- Almaguel, Frankis;
- Zboralski, Dirk;
- Osterkamp, Frank;
- Hoehne, Aileen;
- Reineke, Ulrich;
- Smerling, Christiane;
- Kulkarni, Harshad R.
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: Firstin-Human Results. .
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259192
By:
- Baum, Richard P.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Chantadisai, Maythinee;
- Robiller, Franz C.;
- Jingjing Zhang;
- Mueller, Dirk;
- Eismant, Alexander;
- Almaguel, Frankis;
- Zboralski, Dirk;
- Osterkamp, Frank;
- Hoehne, Aileen;
- Reineke, Ulrich;
- Smerling, Christiane;
- Kulkarni, Harshad R.
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: First-in-Human Results.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259192
By:
- Baum, Richard P.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Maythinee Chantadisai;
- Robiller, Franz C.;
- Jingjing Zhang;
- Mueller, Dirk;
- Eismant, Alexander;
- Almaguel, Frankis;
- Zboralski, Dirk;
- Osterkamp, Frank;
- Hoehne, Aileen;
- Reineke, Ulrich;
- Smerling, Christiane;
- Kulkarni, Harshad R.
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: First-in-Human Results.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259192
By:
- Baum, Richard P.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Maythinee Chantadisai;
- Robiller, Franz C.;
- Jingjing Zhang;
- Mueller, Dirk;
- Eismant, Alexander;
- Almaguel, Frankis;
- Zboralski, Dirk;
- Osterkamp, Frank;
- Hoehne, Aileen;
- Reineke, Ulrich;
- Smerling, Christiane;
- Kulkarni, Harshad R.
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: Firstin-Human Results.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259192
By:
- Baum, Richard P.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Chantadisai, Maythinee;
- Robiller, Franz C.;
- Jingjing Zhang;
- Mueller, Dirk;
- Eismant, Alexander;
- Almaguel, Frankis;
- Zboralski, Dirk;
- Osterkamp, Frank;
- Hoehne, Aileen;
- Reineke, Ulrich;
- Smerling, Christiane;
- Kulkarni, Harshad R.
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
First-in-Human Application of Terbium-161: A Feasibility Study Using 161Tb-DOTATOC.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.258376
By:
- Baum, Richard P.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Bernhardt, Peter;
- Rydén, Tobias;
- Schuchardt, Christiane;
- Gracheva, Nadezda;
- Grundler, Pascal V.;
- Köster, Ulli;
- Müller, Dirk;
- Pröhl, Michael;
- Zeevaart, Jan Rijn;
- Schibli, Roger;
- van der Meulen, Nicholas P.;
- Müller, Cristina
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT).
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.241414
By:
- Jingjing Zhang;
- Qingxing Liu;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Baum, Richard P.
Publication type:
Article
Parameters to predict progression free and overall survival after peptide receptor radionuclide therapy: a multivariate analysis in 782 patients.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224386
By:
- Aalbersberg, Else A.;
- Huizing, Daphne M. V.;
- Walraven, Iris;
- de Wit – van der Veen, Berlinda J.;
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Stokkel, Marcel P. M.;
- Baum, Richard P.
Publication type:
Article
177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients with a single functioning kidney.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.223149
By:
- Jingjing Zhang;
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Schuchardt, Christiane;
- Niepsch, Karin;
- Langbein, Thomas;
- Baum, Richard P.
Publication type:
Article
Clinical outcomes of 177 Lu-PSMA radioligand therapy in taxane chemotherapy pretreated and taxane chemotherapy naïve patients with metastatic castration resistant prostate cancer.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.216820
By:
- Barber, Thomas W.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Niepsch, Karin;
- Billah, Baki;
- Baum, Richard P.
Publication type:
Article
177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 11, p. 1579, doi. 10.2967/jnumed.118.223149
By:
- Jingjing Zhang;
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Schuchardt, Christiane;
- Niepsch, Karin;
- Langbein, Thomas;
- Baum, Richard P.
Publication type:
Article
Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1259, doi. 10.2967/jnumed.118.224386
By:
- Aalbersberg, Else A.;
- Huizing, Daphne M. V.;
- Walraven, Iris;
- de Wit-van der Veen, Berlinda J.;
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Stokkel, Marcel P. M.;
- Baum, Richard P.
Publication type:
Article
Clinical Outcomes of 177Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 955, doi. 10.2967/jnumed.118.216820
By:
- Barber, Thomas W.;
- Singh, Aviral;
- Kulkarni, Harshad R.;
- Niepsch, Karin;
- Billah, Baki;
- Baum, Richard P.
Publication type:
Article
Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 377, doi. 10.2967/jnumed.118.215848
By:
- Jingjing Zhang;
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Niepsch, Karin;
- Müller, Dirk;
- Baum, Richard P.
Publication type:
Article
177Lu-3BP-227 for Neurotensin Receptor 1–Targeted Therapy of Metastatic Pancreatic Adenocarcinoma: First Clinical Results.
Published in:
Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 809, doi. 10.2967/jnumed.117.193847
By:
- Baum, Richard P.;
- Singh, Aviral;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Klette, Ingo;
- Wiessalla, Stefan;
- Osterkamp, Frank;
- Reineke, Ulrich;
- Smerling, Christiane
Publication type:
Article
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 85, doi. 10.2967/jnumed.116.183194
By:
- Rahbar, Kambiz;
- Ahmadzadehfar, Hojjat;
- Kratochwil, Clemens;
- Haberkorn, Uwe;
- Schäfers, Michael;
- Essler, Markus;
- Baum, Richard P.;
- Kulkarni, Harshad R.;
- Schmidt, Matthias;
- Drzezga, Alexander;
- Bartenstein, Peter;
- Pfestroff, Andreas;
- Luster, Markus;
- Lützen, Ulf;
- Marx, Marlies;
- Prasad, Vikas;
- Brenner, Winfried;
- Heinzel, Alexander;
- Mottaghy, Felix M.;
- Ruf, Juri
Publication type:
Article
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
Published in:
Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 75, doi. 10.2967/jnumed.116.178889
By:
- Nock, Berthold A.;
- Kaloudi, Aikaterini;
- Lymperis, Emmanouil;
- Giarika, Athina;
- Kulkarni, Harshad R.;
- Klette, Ingo;
- Singh, Aviral;
- Krenning, Eric P.;
- de Jong, Marion;
- Maina, Theodosia;
- Baum, Richard P.
Publication type:
Article
PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.
Published in:
Journal of Nuclear Medicine, 2016, v. 57, p. 97S, doi. 10.2967/jnumed.115.170167
By:
- Kulkarni, Harshad R.;
- Singh, Aviral;
- Schuchardt, Christiane;
- Niepsch, Karin;
- Sayeg, Manal;
- Leshch, Yevgeniy;
- Wester, Hans-Juergen;
- Baum, Richard P.
Publication type:
Article
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.
Published in:
Journal of Nuclear Medicine, 2016, v. 57, n. 7, p. 1006, doi. 10.2967/jnumed.115.168443
By:
- Baum, Richard P.;
- Kulkarni, Harshad R.;
- Schuchardt, Christiane;
- Singh, Aviral;
- Wirtz, Martina;
- Wiessalla, Stefan;
- Schottelius, Margret;
- Mueller, Dirk;
- Klette, Ingo;
- Wester, Hans-Jürgen
Publication type:
Article
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 8, p. 1169, doi. 10.2967/jnumed.115.158550
By:
- Weineisen, Martina;
- Schottelius, Margret;
- Simecek, Jakub;
- Baum, Richard P.;
- Yildiz, Akin;
- Beykan, Seval;
- Kulkarni, Harshad R.;
- Lassmann, Michael;
- Klette, Ingo;
- Eiber, Matthias;
- Schwaiger, Markus;
- Wester, Hans-Jürgen
Publication type:
Article
Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides.
Published in:
PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162303
By:
- Kletting, Peter;
- Schuchardt, Christiane;
- Kulkarni, Harshad R.;
- Shahinfar, Mostafa;
- Singh, Aviral;
- Glatting, Gerhard;
- Baum, Richard P.;
- Beer, Ambros J.
Publication type:
Article
Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with 177 Lu-PSMA and Combined 225 Ac- and 177 Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.
Published in:
Diagnostics (2075-4418), 2022, v. 12, n. 8, p. 1926, doi. 10.3390/diagnostics12081926
By:
- Langbein, Thomas;
- Kulkarni, Harshad R.;
- Schuchardt, Christiane;
- Mueller, Dirk;
- Volk, Gerd Fabian;
- Baum, Richard P.
Publication type:
Article
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 1, p. 113, doi. 10.1007/s00259-020-04797-9
By:
- Ahmadzadehfar, Hojjat;
- Rahbar, Kambiz;
- Baum, Richard P.;
- Seifert, Robert;
- Kessel, Katharina;
- Bögemann, Martin;
- Kulkarni, Harshad R;
- Zhang, Jingjing;
- Gerke, Carolin;
- Fimmers, Rolf;
- Kratochwil, Clemens;
- Rathke, Hendrik;
- Ilhan, Harun;
- Maffey-Steffan, Johanna;
- Sathekge, Mike;
- Kabasakal, Levent;
- Garcia-Perez, Francisco Osvaldo;
- Kairemo, Kalevi;
- Maharaj, Masha;
- Paez, Diana
Publication type:
Article

Found: 45